Sachiko Moriyama
-
- Receptor Mechanisms and Signaling 5
-
- Cancer-related Molecular Pathways 3
-
- Tumors and Oncological Cases 1
-
- Metastasis and carcinoma case studies 2
- Neonatal Respiratory Health Research 2
- Lung Cancer Treatments and Mutations 2
- Aortic Disease and Treatment Approaches 1
-
- Inflammatory mediators and NSAID effects 1
- Co-authors
- Masashi FukayamaYoshihiro NishimuraNobuaki FunataToshiro ShibanoToshiro NikiAkiteru GotoHiroyuki AburataniTakeshi Fujii
- Journals
- Journal of Medicinal Chemistry (1 paper)Arteriosclerosis Thrombosis and Vascular Biology (1 paper)International Journal of Cancer (4 papers)
- Partner nations
- JapanSwitzerlandGermany
In The Last Decade
Sachiko Moriyama
18 papers receiving 354 citations
Peers
Comparison fields: 5 of 58
- Cancer Research 73
- Molecular Biology 221
- Oncology 80
- Cardiology and Cardiovascular Medicine 56
- Pathology and Forensic Medicine 39
Countries citing papers authored by Sachiko Moriyama
This map shows the geographic impact of Sachiko Moriyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sachiko Moriyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sachiko Moriyama more than expected).
Fields of papers citing papers by Sachiko Moriyama
This network shows the impact of papers produced by Sachiko Moriyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sachiko Moriyama. The network helps show where Sachiko Moriyama may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sachiko Moriyama, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 20 | |
| 2 | 2018 | 21 | |
| 3 | 2005 | 64 | |
| 4 | 2004 | 39 | |
| 5 | 2003 | 23 | |
| 6 | [Alveolar hemorrhage as a possible adverse drug reaction by gefitinib (ZD1839, Iressa)]. | 2003 | 5 |
| 7 | 2002 | 6 | |
| 8 | 2002 | 11 | |
| 9 | 2002 | 36 | |
| 10 | Effects of recombinant tissue-type plasminogen activator on life-threatening acute pulmonary thromboembolism in a canine model: a comparative study of e6010 and alteplase. | 2000 | 4 |
| 11 | 1999 | 60 | |
| 12 | 1999 | 2 | |
| 13 | 1999 | 34 | |
| 14 | 1999 | 8 | |
| 15 | 1999 | 3 | |
| 16 | 1999 | 2 | |
| 17 | 1994 | 20 | |
| 18 | 1993 | 1 |
About Sachiko Moriyama
Sachiko Moriyama is a scholar working on Pulmonary and Respiratory Medicine, Internal Medicine and Otorhinolaryngology, having authored 18 papers that have together received 359 indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (5 papers), Cancer-related Molecular Pathways (3 papers), Metastasis and carcinoma case studies (2 papers), Neonatal Respiratory Health Research (2 papers), Lung Cancer Treatments and Mutations (2 papers), Tumors and Oncological Cases (1 paper), Inflammatory mediators and NSAID effects (1 paper) and Aortic Disease and Treatment Approaches (1 paper). The work is most often cited by research in Cancer Research (73 citations), Molecular Biology (221 citations) and Oncology (80 citations). Sachiko Moriyama has collaborated with scholars based in Japan, Switzerland and Germany. Frequent co-authors include Masashi Fukayama, Yoshihiro Nishimura, Nobuaki Funata, Toshiro Shibano, Toshiro Niki, Akiteru Goto, Hiroyuki Aburatani, Takeshi Fujii, Susumu Nishimura and Yutaka Nakahori. Their work appears in journals such as Journal of Medicinal Chemistry, Arteriosclerosis Thrombosis and Vascular Biology and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.